DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Maxim Group Downgrades Co-Diagnostics to Hold

Maxim Group analyst Jason McCarthy downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Hold.

Benzinga · 03/03/2020 14:58

Maxim Group analyst Jason McCarthy downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Hold.